Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines.

Cunningham, Louise S; McFadden, John P; Basketter, David A; Ferguson, Felicity J; White, Ian R; Kimber, Ian

Cunningham, Louise S; McFadden, John P; Basketter, David A; Ferguson, Felicity J; White, Ian R; Kimber, Ian.

Affiliation

Cunningham LS; Department of Cutaneous Allergy, St. John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
McFadden JP; Department of Cutaneous Allergy, St. John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
Basketter DA; DABMEB Consultancy Ltd, Sharnbrook, UK.
Ferguson FJ; Department of Cutaneous Allergy, St. John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
White IR; Department of Cutaneous Allergy, St. John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
Kimber I; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Contact Dermatitis ; 83(5): 432-435, 2020 Nov.

Article de En | MEDLINE | ID: mdl-32880961

Sujet(s)
Mots clés

COVID; adjuvant; co-operative immune augmentation; co-sensitization; contact allergens; diphenylcyclopropenone; vaccine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pneumopathie virale / Vaccins antiviraux / Infections à coronavirus / Cyclopropanes / Pandémies / Betacoronavirus Limites: Female / Humans / Male Langue: En Journal: Contact Dermatitis Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google